FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年10月31日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存 ...

Summary of Key Points Core Viewpoint - On October 30, 32 Hong Kong-listed companies conducted share buybacks, totaling 34.66 million shares and an aggregate amount of HKD 155 million [1][2]. Group 1: Buyback Details - China Feihe repurchased 12 million shares for HKD 50.23 million, with a highest price of HKD 4.200 and a lowest price of HKD 4.170, bringing its total buyback amount for the year to HKD 129 million [1][2]. - China Petroleum & Chemical Corporation repurchased 4.78 million shares for HKD 19.72 million, with a highest price of HKD 4.220 and a lowest price of HKD 4.100, accumulating a total buyback amount of HKD 794 million for the year [1][2]. - Stone Four Pharmaceutical Group repurchased 5 million shares for HKD 15.41 million, with a highest price of HKD 3.130 and a lowest price of HKD 3.030, totaling HKD 14.81 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 30 was from China Feihe at HKD 50.23 million, followed by China Petroleum & Chemical Corporation at HKD 19.72 million [1][2]. - In terms of share quantity, China Feihe led with 12 million shares repurchased, followed by Stone Four Pharmaceutical Group with 5 million shares and China Petroleum & Chemical Corporation with 4.78 million shares [1][2]. Group 3: Additional Buyback Information - Other notable companies involved in buybacks include Lianlian Digital and Guosheng Tang, with varying amounts and share quantities [1][2]. - The data also includes a detailed table of buybacks from various companies, highlighting their respective share counts, amounts, and price ranges [2][3].

Core Insights - A total of 30 companies conducted share buybacks on October 30, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent [1][2] - The total buyback amount for China Feihe was 50.23 million yuan, with 12 million shares repurchased, representing a significant investment in its own stock [1][2] Summary by Company - **China Feihe (06186)**: Repurchased 12 million shares for 50.23 million yuan; cumulative buybacks for the year reached 30.95 million shares, accounting for 0.341% of total share capital [2] - **China Petroleum & Chemical Corporation (00386)**: Repurchased 4.78 million shares for 19.72 million yuan; cumulative buybacks for the year reached 102 million shares, accounting for 0.080% of total share capital [2] - **Stone Four Pharmaceutical Group (02005)**: Repurchased 5 million shares for 15.41 million yuan; cumulative buybacks for the year reached 44.20 million shares, accounting for 1.498% of total share capital [2] - **Lianlian Digital (02598)**: Repurchased 1.38 million shares for 11.31 million yuan; cumulative buybacks for the year reached 4.45 million shares, accounting for 1.065% of total share capital [2] - **Gushengtang (02273)**: Repurchased 290,100 shares for 8.33 million yuan; cumulative buybacks for the year reached 5.88 million shares, accounting for 2.482% of total share capital [2] - **Lianyi Technology-W (09959)**: Repurchased 2.3 million shares for 7.42 million yuan; cumulative buybacks for the year reached 80.04 million shares, accounting for 3.746% of total share capital [2] - **Mongolian Dairy (02319)**: Repurchased 400,000 shares for 5.70 million yuan; cumulative buybacks for the year reached 22.42 million shares, accounting for 0.573% of total share capital [2] - **Kangchen Pharmaceutical (01681)**: Repurchased 280,000 shares for 4.21 million yuan; cumulative buybacks for the year reached 7.84 million shares, accounting for 9.216% of total share capital [2] - **Other Companies**: Various other companies also participated in buybacks, with amounts ranging from 4.51 million yuan to 6 million yuan, and share counts varying significantly [2]

Core Points - 康臣药业 has been actively repurchasing its shares, with a total of 28,000 shares bought back on October 30 at prices ranging from 14.960 to 15.080 HKD, amounting to 4.2053 million HKD [1] - The stock has seen a decline of 5.94% since the start of the recent repurchase program on October 14, during which the company has repurchased a total of 2.65 million shares for 40.4171 million HKD [1] - Year-to-date, 康臣药业 has conducted 30 repurchase transactions, totaling 7.845 million shares and 98.9482 million HKD in repurchase amounts [1] Repurchase Details - On October 30, 康臣药业 repurchased 28,000 shares at a maximum price of 15.080 HKD and a minimum price of 14.960 HKD, totaling 4.2053 million HKD [2] - The company has consistently repurchased shares over the past 12 days, with the most significant repurchase occurring on October 23, where 42,200 shares were bought back at an average price of 15.040 HKD [1][2] - The cumulative repurchase activity reflects a strategic effort to stabilize the stock price amid a downward trend, as evidenced by the stock's closing price of 15.050 HKD on October 30, down 2.46% for the day [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, intending to repurchase 280,000 shares for a total cost of HKD 4.205 million, scheduled for October 30, 2025 [1] Company Summary - 康臣药业 plans to spend HKD 4.205 million on the repurchase of 280,000 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 FF305 呈交日期： 2025年10月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | ...

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on October 28, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent. Group 1: Buyback Details - China Feihe (06186) repurchased 5.174 million shares for a total of 21.6293 million yuan, representing 0.209% of its total share capital [1][2] - Lianyi Rong Technology (09959) repurchased 1.4625 million shares for 4.7622 million yuan, accounting for 3.638% of its total share capital [2] - Zhongxu Future (09890) repurchased 301,400 shares for 4.4130 million yuan, which is 1.270% of its total share capital [2] Group 2: Other Notable Buybacks - Mengniu Dairy (02319) repurchased 300,000 shares for 4.2977 million yuan, representing 0.563% of its total share capital [2] - Jitu Express (01519) repurchased 385,000 shares for 3.8812 million yuan, which is 0.014% of its total share capital [2] - Kangning Jereh Pharmaceutical (09966) repurchased 320,000 shares for 3.7683 million yuan, accounting for 0.117% of its total share capital [2] Group 3: Additional Companies Involved - Other companies involved in the buyback include: - Guichuang Tongqiao-B (02190) with 50,000 shares repurchased for 1.2065 million yuan [2] - Green City Services (02869) with 208,000 shares repurchased for 969,700 yuan [2] - Tianfu (06868) with 2,000 shares repurchased for 60,400 yuan [3]

Group 1 - The company, 康臣药业, announced a share buyback plan on October 28, 2025, involving an expenditure of HKD 2.4497 million to repurchase 159,000 shares [1] - The repurchase price per share ranged from HKD 15.26 to HKD 15.43 [1]

智通财经APP讯，康臣药业(01681)发布公告，该公司于2025年10月28日斥资244.97万港元回购15.9万股 股份，每股回购价格为15.26-15.43港元。 ...

格隆汇10月28日丨康臣药业(01681.HK)公告，10月28日耗资245万港元回购15.9万股。 ...